[{"orgOrder":0,"company":"Nucleus Network","sponsor":"Bugworks","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"BWC0977","moa":"Bacterial topoisomerase","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"Nucleus Network","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nucleus Network \/ Nucleus Network","highestDevelopmentStatusID":"6","companyTruncated":"Nucleus Network \/ Nucleus Network"},{"orgOrder":0,"company":"Nucleus Network","sponsor":"Annexon Biosciences","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Antibody, Unconjugated","year":"2020","type":"Inapplicable","leadProduct":"ANX009","moa":"C1q","graph1":"Undisclosed","graph2":"Phase I","graph3":"Nucleus Network","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nucleus Network \/ Nucleus Network","highestDevelopmentStatusID":"6","companyTruncated":"Nucleus Network \/ Nucleus Network"},{"orgOrder":0,"company":"Nucleus Network","sponsor":"Amgen Inc","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Peptide, Unconjugated","year":"2010","type":"Inapplicable","leadProduct":"Etelcalcetide","moa":"Calcium sensing receptor","graph1":"Endocrinology","graph2":"Phase III","graph3":"Nucleus Network","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Injection","sponsorNew":"Nucleus Network \/ Nucleus Network","highestDevelopmentStatusID":"10","companyTruncated":"Nucleus Network \/ Nucleus Network"},{"orgOrder":0,"company":"Nucleus Network","sponsor":"Angion Biomedica","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Terevalefim","moa":"Hepatocyte growth factor receptor","graph1":"Undisclosed","graph2":"Phase I","graph3":"Nucleus Network","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nucleus Network \/ Nucleus Network","highestDevelopmentStatusID":"6","companyTruncated":"Nucleus Network \/ Nucleus Network"},{"orgOrder":0,"company":"Nucleus Network","sponsor":"GSK","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2016","type":"Inapplicable","leadProduct":"BOS-356","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"Nucleus Network","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Nucleus Network \/ Nucleus Network","highestDevelopmentStatusID":"6","companyTruncated":"Nucleus Network \/ Nucleus Network"}]